Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 409

1.

Intrathecal Injection in A Rat Model: A Potential Route to Deliver Human Wharton's Jelly-Derived Mesenchymal Stem Cells into the Brain.

Kim H, Na DL, Lee NK, Kim AR, Lee S, Jang H.

Int J Mol Sci. 2020 Feb 13;21(4). pii: E1272. doi: 10.3390/ijms21041272.

2.

Correction to: A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB.

Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW.

Eur J Nucl Med Mol Imaging. 2020 Feb 13. doi: 10.1007/s00259-020-04692-3. [Epub ahead of print]

PMID:
32055964
3.

Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes.

Kim JP, Kim J, Kim Y, Moon SH, Park YH, Yoo S, Jang H, Kim HJ, Na DL, Seo SW, Seong JK.

Eur J Nucl Med Mol Imaging. 2020 Feb 10. doi: 10.1007/s00259-020-04693-2. [Epub ahead of print]

PMID:
32040609
4.

Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment.

Jung YH, Park S, Jang H, Cho SH, Kim SJ, Kim JP, Kim ST, Na DL, Seo SW, Kim HJ.

Sci Rep. 2020 Jan 21;10(1):772. doi: 10.1038/s41598-020-57525-6.

5.

A minimally invasive wirelessly powered brain stimulation system for treating neurological disorders.

Lee H, Lee JS, Chung Y, Jung WR, Seong Kang J, Seo DW, Shon YM, Na DL, Joon Kim S.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:6141-6144. doi: 10.1109/EMBC.2019.8857038.

PMID:
31947245
6.

A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial.

Han HJ, Kim BC, Youn YC, Jeong JH, Kim JH, Lee JH, Park KH, Park KW, Kim EJ, Oh MS, Shim YS, Park HY, Yoon B, Yoon SJ, Cho SJ, Park KC, Na DL, Park SA, Lee JM, Choi SH.

Dement Neurocogn Disord. 2019 Dec;18(4):138-148. doi: 10.12779/dnd.2019.18.4.138. Epub 2019 Dec 13.

7.

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET.

Kim SE, Lee B, Park S, Cho SH, Kim SJ, Kim Y, Jang H, Jeong JH, Yoon SJ, Park KW, Kim EJ, Jung NY, Yoon B, Jang JW, Hong JY, Hwang J, Na DL, Seo SW, Choi SH, Kim HJ.

Alzheimers Res Ther. 2020 Jan 4;12(1):6. doi: 10.1186/s13195-019-0577-x.

8.

Reduced forced vital capacity is associated with cerebral small vessel disease burden in cognitively normal individuals.

Kim Y, Lee H, Son TO, Jang H, Cho SH, Kim SE, Kim SJ, Lee JS, Kim JP, Jung YH, Lockhart SN, Kim HJ, Na DL, Park HY, Seo SW.

Neuroimage Clin. 2019 Dec 24;25:102140. doi: 10.1016/j.nicl.2019.102140. [Epub ahead of print]

9.

Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes.

Kim JP, Kim J, Kim Y, Moon SH, Park YH, Yoo S, Jang H, Kim HJ, Na DL, Seo SW, Seong JK.

Eur J Nucl Med Mol Imaging. 2019 Dec 28. doi: 10.1007/s00259-019-04663-3. [Epub ahead of print] Erratum in: Eur J Nucl Med Mol Imaging. 2020 Feb 10;:.

PMID:
31884562
10.

Presynaptic dopaminergic function in early-onset Alzheimer's disease: an FP-CIT image study.

Jang H, Jang YK, Park S, Kim SE, Kim SJ, Cho SH, Youn J, Seo SW, Kim HJ, Na DL.

Neurobiol Aging. 2020 Feb;86:75-80. doi: 10.1016/j.neurobiolaging.2019.10.007. Epub 2019 Oct 21.

PMID:
31843258
11.

A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB.

Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW.

Eur J Nucl Med Mol Imaging. 2019 Dec 13. doi: 10.1007/s00259-019-04596-x. [Epub ahead of print] Erratum in: Eur J Nucl Med Mol Imaging. 2020 Feb 13;:.

PMID:
31834446
12.

Differences in neuroimaging features of early- versus late-onset nonfluent/agrammatic primary progressive aphasia.

San Lee J, Yoo S, Park S, Kim HJ, Park KC, Seong JK, Suh MK, Lee J, Jang H, Kim KW, Kim Y, Cho SH, Kim SJ, Kim JP, Jung YH, Kim EJ, Suh YL, Lockhart SN, Seeley WW, Na DL, Seo SW.

Neurobiol Aging. 2020 Feb;86:92-101. doi: 10.1016/j.neurobiolaging.2019.10.011. Epub 2019 Nov 26.

PMID:
31784276
13.

Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data.

Kang MJ, Kim SY, Na DL, Kim BC, Yang DW, Kim EJ, Na HR, Han HJ, Lee JH, Kim JH, Park KH, Park KW, Han SH, Kim SY, Yoon SJ, Yoon B, Seo SW, Moon SY, Yang Y, Shim YS, Baek MJ, Jeong JH, Choi SH, Youn YC.

BMC Med Inform Decis Mak. 2019 Nov 21;19(1):231. doi: 10.1186/s12911-019-0974-x.

14.

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum.

Kang SH, Park YH, Lee D, Kim JP, Chin J, Ahn Y, Park SB, Kim HJ, Jang H, Jung YH, Kim J, Lee J, Kim JS, Cheon BK, Hahn A, Lee H, Na DL, Kim YJ, Seo SW.

Dement Neurocogn Disord. 2019 Sep;18(3):77-95. doi: 10.12779/dnd.2019.18.3.77. Epub 2019 Oct 2.

15.

Distributed Patterns of Functional Connectivity Predict Working Memory Performance in Novel Healthy and Memory-impaired Individuals.

Avery EW, Yoo K, Rosenberg MD, Greene AS, Gao S, Na DL, Scheinost D, Constable TR, Chun MM.

J Cogn Neurosci. 2020 Feb;32(2):241-255. doi: 10.1162/jocn_a_01487. Epub 2019 Oct 29.

PMID:
31659926
16.

Author Correction: Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease.

Kim KW, Kwon H, Kim YE, Yoon CW, Kim YJ, Kim YB, Lee JM, Yoon WT, Kim HJ, Lee JS, Jang YK, Kim Y, Jang H, Ki CS, Youn YC, Shin BS, Bang OY, Kim GM, Chung CS, Kim SJ, Na DL, Duering M, Cho H, Seo SW.

Sci Rep. 2019 Oct 15;9(1):15010. doi: 10.1038/s41598-019-51400-9.

17.

Author Correction: Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals.

Jang H, Kang D, Chang Y, Kim Y, Lee JS, Kim KW, Jang YK, Kim HJ, Na DL, Shin HY, Kang M, Guallar E, Cho J, Seo SW.

Sci Rep. 2019 Oct 10;9(1):14825. doi: 10.1038/s41598-019-51401-8.

18.

Amyloid and cerebrovascular burden divergently influence brain functional network changes over time.

Chong JSX, Jang H, Kim HJ, Ng KK, Na DL, Lee JH, Seo SW, Zhou J.

Neurology. 2019 Oct 15;93(16):e1514-e1525. doi: 10.1212/WNL.0000000000008315. Epub 2019 Sep 11. Erratum in: Neurology. 2020 Jan 10;:.

PMID:
31511349
19.

Topographical Heterogeneity of Alzheimer's Disease Based on MR Imaging, Tau PET, and Amyloid PET.

Jeon S, Kang JM, Seo S, Jeong HJ, Funck T, Lee SY, Park KH, Lee YB, Yeon BK, Ido T, Okamura N, Evans AC, Na DL, Noh Y.

Front Aging Neurosci. 2019 Aug 20;11:211. doi: 10.3389/fnagi.2019.00211. eCollection 2019.

20.

Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.

Jang H, Kim HJ, Park S, Park YH, Choe Y, Cho H, Lyoo CH, Yoon U, Lee JS, Kim Y, Kim SJ, Kim JP, Jung YH, Ryu YH, Choi JY, Moon SH, Seong JK, DeCarli C, Weiner MW, Lockhart SN, Cho SH, Na DL, Seo SW.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):292-303. doi: 10.1007/s00259-019-04498-y. Epub 2019 Aug 31.

PMID:
31471715
21.

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report.

Kim HJ, Cho H, Park S, Jang H, Ryu YH, Choi JY, Moon SH, Oh SJ, Oh M, Na DL, Lyoo CH, Kim EJ, Seeley WW, Kim JS, Choi KC, Seo SW.

BMC Neurol. 2019 Aug 29;19(1):211. doi: 10.1186/s12883-019-1434-z.

22.

Sex-specific relationship of cardiometabolic syndrome with lower cortical thickness.

Kim SE, Lee JS, Woo S, Kim S, Kim HJ, Park S, Lee BI, Park J, Kim Y, Jang H, Kim SJ, Cho SH, Lee B, Lockhart SN, Na DL, Seo SW.

Neurology. 2019 Sep 10;93(11):e1045-e1057. doi: 10.1212/WNL.0000000000008084. Epub 2019 Aug 23.

PMID:
31444241
23.

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers.

Jang H, Park J, Woo S, Kim S, Kim HJ, Na DL, Lockhart SN, Kim Y, Kim KW, Cho SH, Kim SJ, Seong JK, Seo SW; Alzheimer’s Disease Neuroimaging Initiative.

Neuroimage Clin. 2019;24:101941. doi: 10.1016/j.nicl.2019.101941. Epub 2019 Jul 19.

24.

Development of wirelessly-powered, extracranial brain activator (ECBA) in a large animal model for the future non-invasive human neuromodulation.

Lee H, Lee JS, Chung Y, Chung WR, Kim SJ, Kang JS, Park SM, Kang W, Seo DW, Na DL, Shon YM.

Sci Rep. 2019 Jul 29;9(1):10906. doi: 10.1038/s41598-019-47383-2.

25.

Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).

Jo H, Kim M, Park S, Park JE, Cho SH, Kim SJ, Jang H, Jung YH, Kim J, Na DL, Seo SW, Cho JW, Kim HJ.

J Alzheimers Dis. 2019;71(1):7-13. doi: 10.3233/JAD-190469.

PMID:
31322578
26.

The First Generation of iPSC Line from a Korean Alzheimer's Disease Patient Carrying APP-V715M Mutation Exhibits a Distinct Mitochondrial Dysfunction.

Li L, Roh JH, Kim HJ, Park HJ, Kim M, Koh W, Heo H, Chang JW, Nakanishi M, Yoon T, Na DL, Song J.

Exp Neurobiol. 2019 Jun;28(3):329-336. doi: 10.5607/en.2019.28.3.329. Epub 2019 May 14.

27.

Distinct Brain Regions in Physiological and Pathological Brain Aging.

Lee JS, Park YH, Park S, Yoon U, Choe Y, Cheon BK, Hahn A, Cho SH, Kim SJ, Kim JP, Jung YH, Park KC, Kim HJ, Jang H, Na DL, Seo SW.

Front Aging Neurosci. 2019 Jun 18;11:147. doi: 10.3389/fnagi.2019.00147. eCollection 2019.

28.

APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms.

Charidimou A, Zonneveld HI, Shams S, Kantarci K, Shoamanesh A, Hilal S, Yates PA, Boulouis G, Na HK, Pasi M, Biffi A, Chai YL, Chong JR, Wahlund LO, Clifford JR, Chen C, Gurol ME, Goldstein JN, Na DL, Barkhof F, Seo SW, Rosand J, Greenberg SM, Viswanathan A.

Neurology. 2019 Jul 23;93(4):e358-e371. doi: 10.1212/WNL.0000000000007818. Epub 2019 Jun 26.

PMID:
31243071
29.

Analysis of dementia-related gene variants in APOE ε4 noncarrying Korean patients with early-onset Alzheimer's disease.

Park JE, Kim HJ, Kim YE, Jang H, Cho SH, Kim SJ, Na DL, Won HH, Ki CS, Seo SW.

Neurobiol Aging. 2020 Jan;85:155.e5-155.e8. doi: 10.1016/j.neurobiolaging.2019.05.009. Epub 2019 May 22.

PMID:
31217084
30.

Machine learning based hierarchical classification of frontotemporal dementia and Alzheimer's disease.

Kim JP, Kim J, Park YH, Park SB, Lee JS, Yoo S, Kim EJ, Kim HJ, Na DL, Brown JA, Lockhart SN, Seo SW, Seong JK.

Neuroimage Clin. 2019;23:101811. doi: 10.1016/j.nicl.2019.101811. Epub 2019 Apr 3.

31.

Clinical Effects of Frontal Behavioral Impairment: Cortical Thickness and Cognitive Decline in Individuals with Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment.

Kim SJ, Jung NY, Kim YJ, Park SB, Kim K, Kim Y, Jang H, Kim SE, Cho SH, Kim JP, Jung YH, Woo SY, Kim SW, Lockhart SN, Kim EJ, Kim HJ, Lee JM, Chin J, Na DL, Seo SW.

J Alzheimers Dis. 2019;69(1):213-225. doi: 10.3233/JAD-190007.

PMID:
30958372
32.

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.

Jang H, Jang YK, Kim HJ, Werring DJ, Lee JS, Choe YS, Park S, Lee J, Kim KW, Kim Y, Cho SH, Kim SE, Kim SJ, Charidimou A, Na DL, Seo SW.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1287-1298. doi: 10.1007/s00259-019-04314-7. Epub 2019 Apr 2.

PMID:
30937462
33.

Exposure to ambient fine particles and neuropsychiatric symptoms in cognitive disorder: A repeated measure analysis from the CREDOS (Clinical Research Center for Dementia of South Korea) study.

Lee H, Kang JM, Myung W, Choi J, Lee C, Na DL, Kim SY, Lee JH, Han SH, Choi SH, Kim SY, Cho SJ, Yeon BK, Kim DK, Lewis M, Lee EM, Kim CT, Kim H.

Sci Total Environ. 2019 Jun 10;668:411-418. doi: 10.1016/j.scitotenv.2019.02.447. Epub 2019 Mar 2.

PMID:
30852217
34.

Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.

Franzmeier N, Rubinski A, Neitzel J, Kim Y, Damm A, Na DL, Kim HJ, Lyoo CH, Cho H, Finsterwalder S, Duering M, Seo SW, Ewers M; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2019 Apr 1;142(4):1093-1107. doi: 10.1093/brain/awz026.

PMID:
30770704
35.

Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals.

Jang H, Kang D, Chang Y, Kim Y, Lee JS, Kim KW, Jang YK, Kim HJ, Na DL, Shin HY, Kang M, Guallar E, Cho J, Seo SW.

Sci Rep. 2019 Feb 12;9(1):1814. doi: 10.1038/s41598-018-38357-x. Erratum in: Sci Rep. 2019 Oct 10;9(1):14825.

36.

Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease.

Kim KW, Kwon H, Kim YE, Yoon CW, Kim YJ, Kim YB, Lee JM, Yoon WT, Kim HJ, Lee JS, Jang YK, Kim Y, Jang H, Ki CS, Youn YC, Shin BS, Bang OY, Kim GM, Chung CS, Kim SJ, Na DL, Duering M, Cho H, Seo SW.

Sci Rep. 2019 Jan 28;9(1):787. doi: 10.1038/s41598-018-36580-0. Erratum in: Sci Rep. 2019 Oct 15;9(1):15010.

37.

Cerebrospinal fluid from Alzheimer's disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer's disease.

Lee J, Kwon SJ, Kim JH, Jang H, Lee NK, Hwang JW, Kim JH, Chang JW, Na DL.

Sci Rep. 2019 Jan 24;9(1):564. doi: 10.1038/s41598-018-37252-9.

38.

Data-driven prognostic features of cognitive trajectories in patients with amnestic mild cognitive impairments.

Kim YJ, Cho SK, Kim HJ, Lee JS, Lee J, Jang YK, Vogel JW, Na DL, Kim C, Seo SW.

Alzheimers Res Ther. 2019 Jan 22;11(1):10. doi: 10.1186/s13195-018-0462-z.

39.

White Matter Network Disruption and Cognitive Dysfunction in Neuromyelitis Optica Spectrum Disorder.

Cho EB, Han CE, Seo SW, Chin J, Shin JH, Cho HJ, Seok JM, Kim ST, Kim BJ, Na DL, Lee KH, Seong JK, Min JH.

Front Neurol. 2018 Dec 17;9:1104. doi: 10.3389/fneur.2018.01104. eCollection 2018.

40.

18F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia.

Cho H, Kim HJ, Choi JY, Ryu YH, Lee MS, Na DL, Seo SW, Lyoo CH.

Neurobiol Aging. 2019 Mar;75:187-197. doi: 10.1016/j.neurobiolaging.2018.11.017. Epub 2018 Nov 23.

PMID:
30594046
41.

Subcortical Ischemic Change as a Predictor of Driving Cessation in the Elderly.

Jang M, Hong CH, Kim HC, Choi SH, Seo SW, Kim SY, Na DL, Lee Y, Chang KJ, Roh HW, Son SJ.

Psychiatry Investig. 2018 Dec;15(12):1162-1167. doi: 10.30773/pi.2018.10.10.3. Epub 2018 Nov 26.

42.

The Brain Donation Program in South Korea.

Kim Y, Suh YL, Kim SJ, Bae MH, Kim JB, Kim Y, Choi KC, Huh GY, Kim EJ, Lee JS, Kang HW, Shim SM, Lim HJ, Koh YH, Kim BC, Lee KH, Lee MC, Lee HW, Lim TS, Seeley WW, Kim HJ, Na DL, Lee KH, Seo SW.

Yonsei Med J. 2018 Dec;59(10):1197-1204. doi: 10.3349/ymj.2018.59.10.1197.

43.

Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.

Jung NY, Han JC, Ong YT, Cheung CY, Chen CP, Wong TY, Kim HJ, Kim YJ, Lee J, Lee JS, Jang YK, Kee C, Lee KH, Kim EJ, Seo SW, Na DL.

J Neurol Sci. 2019 Jan 15;396:94-101. doi: 10.1016/j.jns.2018.10.025. Epub 2018 Oct 31.

PMID:
30447606
44.

iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia.

Li L, Roh JH, Chang EH, Lee Y, Lee S, Kim M, Koh W, Chang JW, Kim HJ, Nakanishi M, Barker RA, Na DL, Song J.

Exp Neurobiol. 2018 Oct;27(5):350-364. doi: 10.5607/en.2018.27.5.350. Epub 2018 Oct 31.

45.

Cortical atrophy pattern-based subtyping predicts prognosis of amnestic MCI: an individual-level analysis.

Kim HJ, Park JY, Seo SW, Jung YH, Kim Y, Jang H, Kim ST, Seong JK, Na DL.

Neurobiol Aging. 2019 Feb;74:38-45. doi: 10.1016/j.neurobiolaging.2018.10.010. Epub 2018 Oct 12.

PMID:
30415126
46.

Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment.

Jang H, Park JY, Jang YK, Kim HJ, Lee JS, Na DL, Noh Y, Lockhart SN, Seong JK, Seo SW.

Sci Rep. 2018 Nov 1;8(1):16178. doi: 10.1038/s41598-018-34032-3.

47.

Risk Factors of Behavioral and Psychological Symptoms in Patients with Alzheimer Disease: The Clinical Research of Dementia of South Korea Study.

Park S, Kim DK, Myung W, Yoo JH, Shin SJ, Na DL, Kim SY, Lee JH, Kim SY, Han SH, Choi SH, Shin J.

Korean J Fam Med. 2019 Jan;40(1):16-21. doi: 10.4082/kjfm.17.0061. Epub 2018 Oct 29.

48.

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.

Kim SE, Woo S, Kim SW, Chin J, Kim HJ, Lee BI, Park J, Park KW, Kang DY, Noh Y, Ye BS, Yoo HS, Lee JS, Kim Y, Kim SJ, Cho SH, Na DL, Lockhart SN, Jang H, Seo SW.

J Alzheimers Dis. 2018;66(2):681-691. doi: 10.3233/JAD-180048.

PMID:
30320571
49.

The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis.

Jung NY, Cho H, Kim YJ, Kim HJ, Lee JM, Park S, Kim ST, Kim EJ, Kim JS, Moon SH, Lee JH, Ewers M, Na DL, Seo SW.

Alzheimers Res Ther. 2018 Sep 27;10(1):103. doi: 10.1186/s13195-018-0432-5.

50.

Biological Brain Age Prediction Using Cortical Thickness Data: A Large Scale Cohort Study.

Aycheh HM, Seong JK, Shin JH, Na DL, Kang B, Seo SW, Sohn KA.

Front Aging Neurosci. 2018 Aug 22;10:252. doi: 10.3389/fnagi.2018.00252. eCollection 2018.

Supplemental Content

Loading ...
Support Center